Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Neoplasms 6 Head and Neck Neoplasms 4 Colorectal Neoplasms 4 Breast Neoplasms 4 Stomach Neoplasms 3 Pancreatic Neoplasms 3 Malnutrition 3 Carcinoma, Non-Small-Cell Lung 3 Prostatic Neoplasms 2 Lung Neoplasms 2 Locally Advanced Head and Neck Carcinoma 2 Esophageal Neoplasms 2 Colonic Neoplasms 2 Carcinoma, Hepatocellular 2 Biliary Tract Neoplasms 2 Wilms Tumor 1 Surgery--Complications 1 Sarcoma 1 Prostatic Intraepithelial Neoplasia 1 Peripheral Nervous System Diseases 1 Peptic Ulcer 1 Nutrition Related Cancer 1 Neurotoxicity Syndromes 1 Neurofibromatosis 1 1 Neuroectodermal Tumors, Primitive, Peripheral 1 Nasopharyngeal Carcinoma 1 Multiple Endocrine Neoplasia Type 1 1 Mucositis 1 Motor Activity 1 Malabsorption Syndromes 1

Interventions

AZD 6244 9 Lovastatin 5 Deoxycholic Acid 4 trametinib 3 Lasers, Solid-State 3 mirdametinib 2 fludarabine 2 Transcranial Direct Current Stimulation 2 Sirolimus 2 Polidocanol 2 Magnetic Resonance Imaging 2 Lasers 2 Lamotrigine 2 Inhalation 2 Acetylcysteine 2 thymoglobulin 1 talimogene laherparepvec 1 peginterferon alfa-2b 1 gadolinium compound P760 1 fludarabine phosphate 1 diphenylcyclopropenone 1 cabozantinib 1 binimetinib 1 X-Rays 1 Vitamin D 1 Vincristine 1 Vinblastine 1 Temozolomide 1 Surgical Procedures, Operative 1 Sunitinib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Neurofibromatosis 1 × Dietary Supplements × Clear all

NCT01968590 2022-05-25

VitDBoneNF1

University of Utah

Phase 2 Terminated

Neurofibromatosis 1

Data powered by HemOnc (CC BY 4.0) Colophon ⚡